Website: synbio-tech.com   |   LinkedIn: linkedin.com/company/synbio-technologies

Read, Write, and Edit DNA, at Scale

How Synbio Technologies delivers cost-effective synthetic biology solutions to researchers worldwide

At a glance

  • Company: Synbio Technologies (synbio-tech.com)
  • Founded: 2013, by synthetic biologists with decades of industry experience
  • S. headquarters: Monmouth Junction, New Jersey
  • Focus: DNA reading (sequencing), writing (synthesis), and editing (engineering), plus RNA and protein solutions
  • Working with PSG on: Fractional commercialization services

A mission built on DNA

Synbio Technologies was founded with a single mission: to empower scientific discovery and drug innovation by providing advanced, cost-effective DNA technology platforms. Its vision is to become the most trusted DNA synthesis company in the world.

Today the company has more than 250 scientific staff, and its production facility is certified to ISO 9001 and ISO 13485, among the highest standards for DNA manufacturing.

End-to-end synthetic biology

  • DNA writing: gene synthesis, oligo pools, pathway and genome synthesis, powered by Synbio’s proprietary Syno® DNA synthesis technology
  • DNA engineering: mutagenesis, library construction, and gene editing
  • DNA reading: sequencing services
  • RNA solutions: RNA synthesis for research and therapeutic development
  • Protein solutions: protein expression and antibody production

Applications across the life sciences

Researchers around the world use Synbio’s platforms for diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, and molecular breeding.